Cizutamig: Clinical Trials

6 trials of Cizutamig, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 1 completed, 1 not yet recruiting, 1 withdrawn. 5 Phase 1, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 15Recruiting 3, Completed 1, Withdrawn 1
Early Phase 11Not yet recruiting 1

Follow Cizutamig: new trials by email Literature Review of Cizutamig trials Research Report on Cizutamig

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1 Study of Cizutamig in IgE Mediated Diseases
Cizutamig - IgE-Mediated Hypersensitivity, IgE Mediated Food Allergy
Phase 1WithdrawnCandid Therapeutics2026-04-012026-07-22
A Study of Cizutamig for Patients With Ulcerative Colitis
cizutamig - Ulcerative Colitis (UC)
Early Phase 1Not yet recruitingRuijin Hospital152026-01-012026-01-20
Absolute Bioavailability Study of Cizutamig in Healthy Adult Participants
cizutamig, Placebo - Healthy Participants Study
Phase 1CompletedCandid Therapeutics242025-12-042026-07-22
Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)
Cizutamig - Generalized Myasthenia Gravis
Phase 1RecruitingCandid Therapeutics442025-09-162026-09-02
Clinical Study of Cizutamig in Systemic Lupus Erythematosus
Cizutamig - Systemic Lupus Erythematosus (SLE)
Phase 1RecruitingCandid Therapeutics472025-09-042026-09-02
An Open-label Study of Cizutamig in Refractory Seropositive Rheumatoid Arthritis
Cizutamig - Rheumatoid Arthritis (RA)
Phase 1RecruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology282025-06-232026-01-12

Conditions studied

Arthritis, Rheumatoid (1)  ·  Asthma (1)  ·  Colitis, Ulcerative (1)  ·  Dermatitis, Atopic (1)  ·  Egg Hypersensitivity (1)  ·  Food Hypersensitivity (1)  ·  Hypersensitivity, Immediate (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Milk Hypersensitivity (1)  ·  Myasthenia Gravis (1)  ·  Nut Hypersensitivity (1)  ·  Peanut Hypersensitivity (1)  ·  Rhinitis, Allergic (1)  ·  Rhinosinusitis (1)  ·  Urticaria (1)

Sponsors

Candid Therapeutics (4)  ·  Ruijin Hospital (1)  ·  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)

Countries

China (4)  ·  Australia (2)

Top investigators

Qiubai Li, Professor (1)